SFENCC2020 Society for Endocrinology National Clinical Cases 2020 Poster Presentations (72 abstracts)
Hull York Medical School, Hull, UK
Case history: Adrenal masses are often a diagnostic challenge and can present with unusual symptoms. We describe a case of a 37-year-old male with a background of ulcerative colitis, who presented with bilateral gynecomastia in the breast clinic of, worsening over last one year. He had marked breast tenderness, a decline in his libido but no erectile dysfunction. There was no history of recreational drug use.
Investigations: His serum biochemistry showed a persistently elevated oestradiol and with low testosterone and FSH. His prolactin day curve was within normal limits. Ultrasound testes and MRI pituitary were normal. Subsequently, a CT adrenal showed well defined, enhancing tumour arising from the left adrenal gland measuring 5 cm in the maximum axial dimension. PET-FDG confirmed hypermetabolic tumour on the left adrenal with no distant metastasis.
Results and treatment: Testosterone 2(627) nmol/Lit; FSH 0.20(19) IU/l; Oestradiol 331(0116) pmol/l. A diagnosis of oestradiol secreting adrenal tumour was made, and the patient is listed for urgent surgery. Results of histology will be available after the surgery.
Conclusions and points for discussion: Adrenal masses are often a diagnostic challenge and can present with unusual symptoms such as gynecomastia.
We will discuss rarer causes of gynecomastia including mutations in the CYP19A1 gene (aromatase overactivity), feminising Sertoli cell tumours along with feminising adrenal tumours (FAT).
We will review the current literature for FAT and describe its prevalence, clinical presentation, investigations, treatment options and prognosis.